Biotage appoints Anders Wikström as Vice President of Operations and Anthony Rees as Chief Scientific Officer

​Anders Wikström has been responsible for Biotage’s Research and Development since 2007. Anthony Rees has been CEO of MIP Technolgies, which was recently acquired by Biotage.

”I am really glad to welcome Anthony Rees to Biotage. Anthony has vast experiences of development of both research instruments and consumables within Sample Prep, an important focus area of Biotage. We will have great benefit of Anthony’s knowledge and experience. At the same time I am really pleased that Anders Wikström is taking on the global responsibility for Biotage’s own and out sourced manufacturing. I am convinced that we will see further efficacy gains and lower costs as a result of Anders focused efforts within this area.” says Torben Jørgensen, CEO Biotage AB. 

Contact
Torben Jörgensen, President and CEO
Tel: +46 707 49 05 84, torben.jorgensen@biotage.com

About Biotage
Biotage offers solutions, knowledge and experience in the areas of analytical chemistry and medicinal chemistry. The customers include the world’s largest pharmaceutical and biotech companies, and leading academic institutes. The company is headquartered in Uppsala and has subsidiaries in the US, UK and Japan. Biotage has 245 employees and had sales of 394.1 MSEK in 2009. Biotage is listed on the NASDAQ OMX Nordic Stockholm stock exchange. Website: www.biotage.com